(RTTNews) - 2seventy bio Inc. (TSVT) agreed to be acquired by Bristol Myers Squibb (BMY) at a price of $5.00 per share in an all-cash transaction. This acquisition values the total equity at ...
The move follows through with plans disclosed last year and continues a drug industry trend to lop off costs. Bristol-Myers Squibb Co. will cut 43 scientists from its ranks as it moves to shut ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback